These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
613 related articles for article (PubMed ID: 22466477)
1. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2. Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477 [TBL] [Abstract][Full Text] [Related]
2. Sorafenib prevents human retinal pigment epithelium cells from light-induced overexpression of VEGF, PDGF and PlGF. Kernt M; Neubauer AS; Liegl RG; Hirneiss C; Alge CS; Wolf A; Ulbig MW; Kampik A Br J Ophthalmol; 2010 Nov; 94(11):1533-9. PubMed ID: 20962354 [TBL] [Abstract][Full Text] [Related]
3. Expression and regulation of vascular endothelial growth factor ligands and receptors during menstruation and post-menstrual repair of human endometrium. Punyadeera C; Thijssen VL; Tchaikovski S; Kamps R; Delvoux B; Dunselman GA; de Goeij AF; Griffioen AW; Groothuis PG Mol Hum Reprod; 2006 Jun; 12(6):367-75. PubMed ID: 16648151 [TBL] [Abstract][Full Text] [Related]
5. [Cytoprotective and antiangiogenic effects of the multikinase inhibitor sorafenib on human retinal pigmentepithelium]. Kernt M; Thiele S; Hirneiss C; Neubauer AS; Lackerbauer CA; Wolf A; Eibl KH; Haritoglou C; Ulbig MW; Kampik A Ophthalmologe; 2011 May; 108(5):445-51. PubMed ID: 21253747 [TBL] [Abstract][Full Text] [Related]
6. Sorafenib protects human optic nerve head astrocytes from light-induced overexpression of vascular endothelial growth factor, platelet-derived growth factor, and placenta growth factor. Kernt M; Liegl RG; Rueping J; Neubauer AS; Haritoglou C; Lackerbauer CA; Eibl KH; Ulbig MW; Kampik A Growth Factors; 2010 Jun; 28(3):211-20. PubMed ID: 20166888 [TBL] [Abstract][Full Text] [Related]
7. Immunolocalization and expression of vascular endothelial growth factor receptors (VEGFRs) and neuropilins (NRPs) on keratinocytes in human epidermis. Man XY; Yang XH; Cai SQ; Yao YG; Zheng M Mol Med; 2006; 12(7-8):127-36. PubMed ID: 17088944 [TBL] [Abstract][Full Text] [Related]
8. Axitinib modulates hypoxia-induced blood-retina barrier permeability and expression of growth factors. Kernt M; Thiele S; Liegl RG; Kernt B; Eibl K; Haritoglou C; Ulbig MW; Kampik A Growth Factors; 2012 Feb; 30(1):49-61. PubMed ID: 22168366 [TBL] [Abstract][Full Text] [Related]
9. Intracranial meningiomas, the VEGF-A pathway, and peritumoral brain oedema. Nassehi D Dan Med J; 2013 Apr; 60(4):B4626. PubMed ID: 23651727 [TBL] [Abstract][Full Text] [Related]
10. [Advances of research on vascular endothelial growth factor receptors in epidermal neoplasm]. YANG P; ZHENG M Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 38(4):422-6. PubMed ID: 19693983 [TBL] [Abstract][Full Text] [Related]
11. Influence of ranibizumab on vascular endothelial growth factor plasma level and endothelial progenitor cell mobilization in age-related macular degeneration patients: safety of intravitreal treatment for vascular homeostasis. Machalińska A; Paczkowska E; Pabin T; Safranow K; Karczewicz D; Machaliński B J Ocul Pharmacol Ther; 2011 Oct; 27(5):471-5. PubMed ID: 21830945 [TBL] [Abstract][Full Text] [Related]
12. Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt. Byeon SH; Lee SC; Choi SH; Lee HK; Lee JH; Chu YK; Kwon OW Invest Ophthalmol Vis Sci; 2010 Feb; 51(2):1190-7. PubMed ID: 19834034 [TBL] [Abstract][Full Text] [Related]
13. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma. Straume O; Akslen LA Angiogenesis; 2003; 6(4):295-301. PubMed ID: 15166498 [TBL] [Abstract][Full Text] [Related]
14. Effects of thrombin on RPE cells are mediated by transactivation of growth factor receptors. Hollborn M; Petto C; Steffen A; Trettner S; Bendig A; Wiedemann P; Bringmann A; Kohen L Invest Ophthalmol Vis Sci; 2009 Sep; 50(9):4452-9. PubMed ID: 19369239 [TBL] [Abstract][Full Text] [Related]
16. VEGF receptors are differentially expressed by neuroblastoma cells in culture. Beierle EA; Dai W; Langham MR; Copeland EM; Chen MK J Pediatr Surg; 2003 Mar; 38(3):514-21. PubMed ID: 12632379 [TBL] [Abstract][Full Text] [Related]
17. Anti-angiogenic effects of the receptor tyrosine kinase inhibitor, pazopanib, on choroidal neovascularization in rats. Yafai Y; Yang XM; Niemeyer M; Nishiwaki A; Lange J; Wiedemann P; King AG; Yasukawa T; Eichler W Eur J Pharmacol; 2011 Sep; 666(1-3):12-8. PubMed ID: 21620822 [TBL] [Abstract][Full Text] [Related]
18. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
19. Expression of VEGF and angiopoietins in subfoveal membranes from patients with age-related macular degeneration. Hera R; Keramidas M; Peoc'h M; Mouillon M; Romanet JP; Feige JJ Am J Ophthalmol; 2005 Apr; 139(4):589-96. PubMed ID: 15808152 [TBL] [Abstract][Full Text] [Related]
20. Differential expression of vascular endothelial growth factor A, its receptors VEGFR-1, -2, and -3 and co-receptors neuropilin-1 and -2 does not predict bevacizumab response in human astrocytomas. Baumgarten P; Blank AE; Franz K; Hattingen E; Dunst M; Zeiner P; Hoffmann K; Bähr O; Mäder L; Goeppert B; Machein M; Seifert V; Steinbach JP; Plate KH; Harter PN; Mittelbronn M Neuro Oncol; 2016 Feb; 18(2):173-83. PubMed ID: 26627848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]